United Therapeutics (UTHR)

Add to Watchlists
Create an Alert
96.14 +1.37  +1.45% NASDAQ Apr 15, 5:01PM BATS Real time Currency in USD
View Full Chart
UTHR Price Chart
View All Events

UTHR Events

Date Type Description
Feb 25 Misc United Therapeutics Corporation Q4 2013 Earnings Conference Call
Feb 25 Earnings United Therapeutics Corporation Q4 2013 Earnings Results. Estimate: 1.68.
Oct 29 Misc United Therapeutics Third Quarter 2013 Financial Results Conference Call
Oct 29 Earnings United Therapeutics Third Quarter 2013 Financial Results. Estimate: 1.56.
Jul 25 Earnings United Therapeutics Corporation to Announce Second Quarter 2013 Financial Results Before Market Open on Thursday, July 25, 2013. Estimate: 1.51.
Jun 26 Misc AGM Event for United Therapeutics Corp
Apr 25 Misc United Therapeutics Corporation First Quarter Earnings Conference Call
Apr 25 Earnings United Therapeutics Corporation to Announce First Quarter 2013 Financial Results Before Market Open on Thursday, April 25, 2013. Estimate: 1.46.
View All Performance Charts

UTHR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). United Therapeutics is up 55.89% over the last year vs S&P 500 Total Return up 18.46%, Pluristem Therapeutic up 11.07%, and Siga Technologies down 15.71%.

Get Quote for

Pro Report PDF for UTHR

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download UTHR Pro Report PDF

Pro Strategies Featuring UTHR

Did United Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

UTHR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer. The company's products include Remodulin, Tyvaso and Adcirc. The company operates through two business segments: Pharmaceuticals and Telemedicine. Its lead product, Remodulin, is approved in the U.S. and various countries around the world for both continuous subcutaneous and continuous intravenous infusion for the treatment of pulmonary arterial hypertension (PAH). In addition to prostacyclin analogs like Remodulin, United Therapeutics develops Glycobiological Antiviral Agents for the treatment of infectious diseases, such as Hepatitis C. The company was founded by Martine Rothblatt in June 26, 1996 and is headquartered in Silver Spring, Maryland.

Recent Quotes

Symbol Price Chg Chg % Market Cap
UTHR 96.14 +1.37 +1.45% 4.844B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.